Former Electives

Rashmi Goswami, MD, PhD, FRCPC, FCAP

Staff Hematopathologist and Assistant Professor, Department of Laboratory Medicine and Pathobiology

Dr. Goswami obtained her medical degree from the University of Toronto and subsequently accepted an Anatomical Pathology residency position at McGill University. She has spent three elective months at Dr. Done's lab to learn more about the program and gain experience in molecular pathology (2005). Upon completion of her residency she became a fellow in the CIHR Clinician-Scientist Training Program in Molecular Oncologic Pathology under the supervision of Dr. Suzanne Kamel-Reid. During this time she worked on a number of projects including the proteomic analysis of acute promyelocytic leukemia, the genetics and epigenetics of head and neck carcinoma as well as a project on microRNAs as prognostic markers in mantle cell lymphoma, which she defended as a Ph.D. thesis. She continued on to obtain clinical subspecialty training in hematopathology and molecular genetic pathology at the Vancouver General Hospital/British Columbia Cancer Agency and MD Anderson Cancer Center, and holds U.S. board certification in both subspecialties. She is a recipient of several awards including the Ontario Graduate Scholarship, the MD Anderson Cancer Center Fellows’ Research Awards, the USCAP Stowell-Orbison Certificate of Merit, the European Hematology Association/American Society of Hematology Translational Research Training in Hematology Award, the NCIC/Terry Fox Foundation Clinical Research Fellowship and a Canadian Institutes of Health Research Fellowship Award. In August 2015, Dr. Goswami joined University Health Network as a staff hematopathologist and is an assistant professor in the Department of Laboratory Medicine and Pathobiology. Her research interests include applying molecular techniques to assist in the diagnosis and prognosis of solid and hematologic tumours, as well as understanding the genetic and epigenetic landscape of leukemias and lymphomas. In particular she would like to explore how changes to this molecular landscape affect disease pathogenesis.



Catherine Chung, MD, FRCPC

Dr. Catherine Chung completed her medical degree (2003) and anatomic pathology residency (2008) at the University of Toronto. She participated in a research elective in Dr. Tsao's laboratory investigating p16/CDKN2A gene deletion as a candidate biomarker for malignancy in mesothelial proliferative lesions (April 2006). She completed a fellowship in Paediatric Pathology at the Children's Hospital of Philadelphia. Currently, she serves as a Staff Pathologist at Sick Children Hospital in Toronto.







Kenneth Craddock, MD, FRCPC


Assistant Professor & Staff Pathologist

Dr. Craddock received his BSc in Neuroscience (1999) and his MD (2004) at University of Alberta prior starting his residency in Anatomic Pathology at the University of Toronto. During his elective, he worked on a project at Dr. Tsao’s lab in collaboration with Dr. Jurisica, helping to analyze and validate high-resolution genomic DNA copy number data in non-small cell lung carcinomas. Upon completion of residency program, he completed a fellowship in cytogenetics through the Canadian College of Medical Genetics (CCMG), and worked as director of the cancer cytogenetics laboratory at University Health Network in Toronto for 4 years, during which time he continued to work with Dr. Tsao and others on research projects related to FISH applications in lung cancer and haematologic neoplasms. In 2015 he has moved to a broad community pathology practice at Southlake Regional Health Centre in Newmarket, Ontario.

Last Updated ( Monday, 01 June 2009 )